
from
TF Market Research50 page report
published Mar 19, 2006
Price
$2,000.00 available for immediate download

This report is also available for purchase on a
per-page basis.
Report Overview
Purchase by Section
Search Inside
...Par Pharmaceutical Companies, Inc., a holding company, engages in the research, development, manufacture, and distribution of generic drugs in the United States. Its product line comprises generic prescription drugs consisting of ### products representing various dosage strengths for ## separate drugs. The company s generic drug products include central nervous system, cardiovascular, anti -inflammatory, gastrointestinal, and anti -infective treatments. Its products are manufactured principally in the solid oral dosage form consisting of tablets, caplets, and two -piece hard shell capsules. Par Pharmaceutical also distributes one oral suspension product and one product in the semisolid form of a cream. In addition, it designs and develops intermediate ingredients used in the production of finished products for the pharmaceutical industry. The company markets its products under the Par label primarily to wholesalers, retail drug store chains, managed health care providers, and...
Source: LIFE SCIENCE ANALYTICS
Company: PAR PHARMACEUTICAL COMPANIES INC
Geographic Regions: MID-ATLANTIC/MIDDLE ATLANTIC REGION, NORTH AMERICA, NEW YORK (STATE OF), UNITED STATES OF AMERICA
TF Market ResearchTF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.